{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-157867","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2025-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.225934+00:00","generated_at":"2026-05-18T06:57:40.081493+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ISS and Glass Lewis recommend Ikena stockholders vote FOR Inmagene merger","bullets":["Institutional Shareholder Services (ISS) and Glass Lewis recommend voting FOR share issuance related to merger with Inmagene.","Ikena's Annual Meeting is July 15, 2025; record date was May 22, 2025.","Inmagene's lead candidate is IMG-007, a nondepleting anti-OX40 mAb for immune & inflammatory diseases.","CEO Mark Manfredi cited IMG-007's potential to build shareholder value in I&I space.","Proxy includes seven proposals; all votes are important for merger approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-157867","json":"https://secwatch.observer/filing/0001193125-25-157867.json","markdown":"https://secwatch.observer/filing/0001193125-25-157867.md","text":"https://secwatch.observer/filing/0001193125-25-157867.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525157867/0001193125-25-157867-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525157867/d826245d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:57:40.081493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}